Francisco Díaz-Massó – President, BLDM, Puerto Rico
Established 57 years ago, Bermudez, Longo, Díaz-Massó (BLDM) has played a key role in the rapid urbanization and industrialization of Puerto Rico, and today is the top specialty electrical and…
The CDI mission is to empower research and development in proteomics with proprietary technologies, making possible — today — the protein discoveries of tomorrow. CDI’s HuProt protein microarrays and related services make it possible to perform rapid and efficient analyses of thousands of protein interactions using minimal amounts of valuable research or clinical samples.
The company’s microarray-powered monoclonal antibodies (MAbs] and MAb-related services provide unprecedented levels of specificity. Our system of antibody production is part of the NIH Protein Capture Reagents program and is currently working to produce truly mono-specific antibodies to human transcription factors.
CDI has patents in process for technologies to increase high through put analysis of protein-protein interactions as well as high throughput development of antibodies and identification of biomarkers
At CDI we believe that partnering with both companies and academic scientists is the path to mutual success. So please contact our business development professionals for possible collaborations or partnerships.
The Company has locations in Baltimore, Maryland and in Mayaguez, Puerto Rico.
Contact details
Guanajibo Research and Innovation Park
4005 Street B, Road 114 Km 1.3
Mayaguez, PR 00682
USA
T: 787-806-4010
F: 787-806-4006
www.cdi-lab.com
Established 57 years ago, Bermudez, Longo, Díaz-Massó (BLDM) has played a key role in the rapid urbanization and industrialization of Puerto Rico, and today is the top specialty electrical and…
Dr. Carlos Rivera Velez, president of the Puerto Rican Medical Device Cluster, shares the importance of the medtech industry for Puerto Rico and how the cluster is working with various…
Felix Negrón, VP of Puerto Rico Operations for Medtronic, the largest life sciences company on the island, explains their unique footprint in Puerto Rico and what the company has learnt…
Exel F. Colon, President of ECR Engineering, a Puerto Rican company specialized in water and wastewater treatment with expertise in the life sciences industry, explains what makes water critical for…
Dr Amarilys Silva-Boschetti and Dr Miguel Vázquez-Padua of the Puerto Rico Consortium for Clinical Investigation (PRCCI) underline the various benefits for pharmaceutical, biotechnology and medtech companies to conduct clinical trials…
Jorge Luis Rodriguez, CEO of PACIV, a Puerto Rican provider of industrial automation solutions for the life science’s industry, reveals the three key performance indicators that make the island a…
In June 2019, Sartorius Stedim Biotech inaugurated the USD 130 million expansion of its Yauco site, one of the first multi-million dollar investment projects on the island after Hurricane Maria.…
Since 2001, ETH Cargo has been operating in Puerto Rico, providing international air and ocean freight services, domestic deliveries, US Customs and tax clearance, project cargo and turnkey operations, as…
Jose Viera-Colon, Region Director Caribbean for Allergan, highlights the opportunities and obstacles related to leading the company’s commercial operations in Puerto Rico and countries like the Dominican Republic. He also…
David Fuster, plant manager of the Dorado factory of Chinese pharma outfit PuraCap, shares the company’s strategy behind the investment in Puerto Rico and how the PuraCap Caribe is leveraging…
Iliette Frontera, VP Operations of Boston Scientific in Puerto Rico, shares the significance of the Dorado site within the group’s global supply chain, her four priorities to ensure sustainable growth,…
Dr Rafael Rodríguez Mercado, Secretary of Health for Puerto Rico, explains the priorities his administration has put in place, the impact of Hurricane Maria on the Puerto Rican healthcare system,…
See our Cookie Privacy Policy Here
